Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
2015 · Cell Reports · 178 citations
https://doi.org/10.1016/j.celrep.2015.08.084
C
Chul‐Yong Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
1.5K
Citations
21
h-index
25
i10-index
Chul‐Yong Park is an academic researcher from Yonsei University. The author has contributed to research in topics: Pluripotent Stem Cells Research & CRISPR and Genetic Engineering & TGF-β signaling in diseases. The author has an h-index of 21, co-authored 35 publications.
ORCID: 0000-0002-4467-9268Papers by this author
worksUniversal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9
2019 · Stem Cell Reports · 43 citations
https://doi.org/10.1016/j.stemcr.2019.04.016
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease
2023 · Cell stem cell · 43 citations
https://doi.org/10.1016/j.stem.2023.11.009
Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
2019 · Experimental & Molecular Medicine · 29 citations
https://doi.org/10.1038/s12276-019-0243-1
Transplantation of PSA-NCAM-Positive Neural Precursors from Human Embryonic Stem Cells Promotes Functional Recovery in an Animal Model of Spinal Cord Injury
2022 · Tissue Engineering and Regenerative Medicine · 11 citations
https://doi.org/10.1007/s13770-022-00483-z
Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs
2025 · Experimental & Molecular Medicine · 5 citations
https://doi.org/10.1038/s12276-024-01375-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat